The Management Of mCRC Patients Receiving Regorafenib

The Management Of mCRC Patients Receiving Regorafenib

User Photo
obr

1 year
55 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Howard Hochster, MD, Associate Director for Clinical Research, Rutgers Cancer institute of New jersey, Director of Oncology Research, RWJBarnabas Health discusses, The Management Of mCRC Patients Receiving Regorafenib. At The 2019 Gastrointestinal Cancers Symposium In San Francisco, CA On Jan 17, 2019. http://obroncology.com
Up Next Autoplay
>